Finance

Lists
MKKGY:OTCMKTS
Merck KGaA
US$32,07
+1,42%
(+0,45) 1D
15 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MKKGY...
Open
US$32,20
High
US$32,20
Low
US$32,01
Mkt. cap
20,67 ຕື້
Avg. vol.
125,93 ພັນ
Volume
54,75 ພັນ
Dividend
1,61%
Quarterly dividend
US$0,13
Ex-dividend date
27 ມ.ສ. 2026
P/E ratio
26,26
52-wk high
US$34,19
52-wk low
US$23,73
EPS
US$1,22
Beta
0,93
Shares outstanding
646,21 ລ້ານ
No. of employees
62 ພັນ
Open
US$32,20
High
US$32,20
Low
US$32,01
Mkt. cap
20,67 ຕື້
Avg. vol.
125,93 ພັນ
Volume
54,75 ພັນ
Dividend
1,61%
Quarterly dividend
US$0,13
Ex-dividend date
27 ມ.ສ. 2026
P/E ratio
26,26
52-wk high
US$34,19
52-wk low
US$23,73
EPS
US$1,22
Beta
0,93
Shares outstanding
646,21 ລ້ານ
No. of employees
62 ພັນ
News stories
From web sources and news partners
Profile
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Shizuoka and Beijing, as well as other Research and Development units in Taiwan, France, Israel, South Korea, India, and the UK. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine. Merck was privately owned until going public on the Frankfurt Stock Exchange in 1995 and is listed on the DAX index of Germany's top companies. The Merck family still controls a majority of 70.3% of the company's shares. Wikipedia
About Merck KGaA
CEO-
Employees62,1 ພັນ
Founded1668
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
5,32 ຕື້
5,25 ຕື້
5,13 ຕື້
5,43 ຕື້
Cost of goods sold
2,10 ຕື້
2,20 ຕື້
2,07 ຕື້
2,27 ຕື້
Cost of revenue
2,10 ຕື້
2,20 ຕື້
2,07 ຕື້
2,27 ຕື້
Research and development expenses
660,00 ລ້ານ
634,00 ລ້ານ
657,70 ລ້ານ
684,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,46 ຕື້
1,54 ຕື້
1,52 ຕື້
1,56 ຕື້
Operating expense
1,99 ຕື້
2,12 ຕື້
2,13 ຕື້
2,41 ຕື້
Total operating expenses
4,10 ຕື້
4,32 ຕື້
4,20 ຕື້
4,68 ຕື້
Operating income
1,22 ຕື້
926,00 ລ້ານ
935,40 ລ້ານ
753,00 ລ້ານ
Other non operating income
1,00 ລ້ານ
4,00 ລ້ານ
-100,00 ພັນ
-1,00 ລ້ານ
EBT including unusual items
1,12 ຕື້
401,00 ລ້ານ
868,70 ລ້ານ
640,00 ລ້ານ
EBT excluding unusual items
1,12 ຕື້
1,10 ຕື້
867,50 ລ້ານ
640,00 ລ້ານ
Income tax expense
225,00 ລ້ານ
77,00 ລ້ານ
200,00 ລ້ານ
146,00 ລ້ານ
Effective tax rate
20,04%
19,20%
23,02%
22,81%
Other operating expenses
-128,00 ລ້ານ
-50,00 ລ້ານ
-45,40 ລ້ານ
164,00 ລ້ານ
Net income
902,00 ລ້ານ
319,00 ລ້ານ
659,40 ລ້ານ
490,00 ລ້ານ
Net profit margin
16,96%
6,08%
12,84%
9,02%
Earnings per share
-
-
-
2,16
Interest and investment income
27,00 ລ້ານ
21,00 ລ້ານ
21,20 ລ້ານ
25,00 ລ້ານ
Interest expense
-126,00 ລ້ານ
-43,00 ລ້ານ
-80,60 ລ້ານ
-137,00 ລ້ານ
Net interest expenses
-99,00 ລ້ານ
-22,00 ລ້ານ
-59,40 ລ້ານ
-112,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
1,68 ຕື້
1,31 ຕື້
1,42 ຕື້
1,25 ຕື້
Gain or loss from assets sale
-174,00 ລ້ານ
6,00 ລ້ານ
-41,90 ລ້ານ
1,00 ລ້ານ
AI content may include mistakes. Learn more
ແອັບຂອງ Google